cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Hookipa Pharma Inc
40 own
75 watching
Current Price
$3.84
$0.03
(0.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
60.39M
52-Week High
52-Week High
11.30000
52-Week Low
52-Week Low
3.41500
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
115.2084
iconMarket Capitalization60.39M
icon52-Week High11.30000
icon52-Week Low3.41500
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio115.2084
What does the Hookipa Pharma Inc do?
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Read More
How much money does Hookipa Pharma Inc make?
News & Events about Hookipa Pharma Inc.
Globe Newswire
1 year ago
NEW YORK and VIENNA, Austria, June 10, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Compensation Committee of the Companys Board of Directors ...
PR Newswire
1 year ago
Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? PR Newswire NEW YORK, May 1, 2023 NEW YORK, May 1, 2023 /PRNewswire...
Globe Newswire
1 year ago
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that a Trial in Progress poster on its ongoing Phase 1/2 clinical study (...
Globe Newswire
1 year ago
NEW YORK and VIENNA, March 08, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release fourth quarter and full year 2022 financial results before ...
Frequently Asked Questions
Frequently Asked Questions
What is Hookipa Pharma Inc share price today?
plus_minus_icon
Can Indians buy Hookipa Pharma Inc shares?
plus_minus_icon
How can I buy Hookipa Pharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Hookipa Pharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Hookipa Pharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Hookipa Pharma Inc?
plus_minus_icon
What is today’s market capitalisation of Hookipa Pharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Hookipa Pharma Inc?
plus_minus_icon
What percentage is Hookipa Pharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Hookipa Pharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.84
$0.03
(0.79%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00